Total Payments
$7,118
2024 Payments
$2,068
Companies
37
Transactions
440
Medicare Patients
1,809
Medicare Billing
$117,847
Payment Breakdown by Category
Food & Beverage$7,091 (99.6%)
Education$26.71 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,091 | 438 | 99.6% |
| Education | $26.71 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,610 | 117 | $0 (2024) |
| Novo Nordisk Inc | $1,243 | 72 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $915.23 | 57 | $0 (2024) |
| Lilly USA, LLC | $444.13 | 30 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $324.94 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $287.84 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $265.58 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $167.00 | 9 | $0 (2024) |
| Amarin Pharma Inc. | $166.76 | 11 | $0 (2022) |
| Astellas Pharma US Inc | $136.77 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,068 | 123 | ABBVIE INC. ($482.90) |
| 2023 | $2,049 | 121 | ABBVIE INC. ($507.61) |
| 2022 | $1,546 | 100 | ABBVIE INC. ($321.02) |
| 2021 | $1,455 | 96 | AbbVie Inc. ($298.59) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Insomnia | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Obesity | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 756 | 1,085 | $124,795 | $49,276 |
| 2022 | 10 | 441 | 798 | $101,255 | $33,594 |
| 2021 | 9 | 319 | 850 | $91,225 | $18,701 |
| 2020 | 8 | 293 | 659 | $66,066 | $16,276 |
Total Patients
1,809
Total Services
3,392
Medicare Billing
$117,847
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 291 | $52,962 | $19,027 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 200 | $25,600 | $8,656 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $15,996 | $8,617 | 53.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 102 | 104 | $12,584 | $6,027 | 47.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 34 | $2,500 | $2,262 | 90.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 99 | 99 | $2,574 | $1,388 | 53.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,700 | $938.52 | 55.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 18 | 24 | $1,320 | $796.26 | 60.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 81 | $4,050 | $633.63 | 15.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,212 | $602.81 | 27.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 15 | $825.00 | $243.00 | 29.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 34 | $816.00 | $74.80 | 9.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 14 | 16 | $384.00 | $5.62 | 1.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 42 | 53 | $1,272 | $4.70 | 0.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 308 | $61,712 | $18,443 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 138 | $17,825 | $7,340 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $5,052 | $2,789 | 55.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 42 | 43 | $5,203 | $2,237 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,192 | $1,733 | 33.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 38 | 70 | $2,951 | $509.28 | 17.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 32 | 32 | $832.00 | $455.99 | 54.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 24 | $487.28 | $48.83 | 10.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 11 | $330.00 | $27.68 | 8.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 34 | 123 | $1,671 | $9.21 | 0.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 307 | $69,655 | $12,734 | 18.3% |
About Ashlea Lamberth, NP
Ashlea Lamberth, NP is a Nurse Practitioner healthcare provider based in Portland, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700820388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashlea Lamberth, NP has received a total of $7,118 in payments from pharmaceutical and medical device companies, with $2,068 received in 2024. These payments were reported across 440 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,091).
As a Medicare-enrolled provider, Lamberth has provided services to 1,809 Medicare beneficiaries, totaling 3,392 services with total Medicare billing of $117,847. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Portland, TN
- Active Since 06/15/2006
- Last Updated 06/08/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1700820388
Products in Payments
- XIFAXAN (Drug) $766.75
- VRAYLAR (Drug) $637.39
- QULIPTA (Drug) $522.79
- Ozempic (Drug) $419.58
- UBRELVY (Drug) $389.49
- Rybelsus (Drug) $372.88
- TRINTELLIX (Drug) $324.94
- TRELEGY ELLIPTA (Drug) $265.58
- FARXIGA (Drug) $224.70
- MOUNJARO (Drug) $216.61
- REXULTI (Drug) $207.21
- Wegovy (Drug) $195.48
- Vascepa (Drug) $166.76
- RYBELSUS (Drug) $165.31
- NURTEC ODT (Drug) $157.05
- JARDIANCE (Drug) $149.80
- TRULANCE (Drug) $135.14
- Edarbi (Drug) $123.82
- Kerendia (Drug) $120.67
- Veozah (Drug) $91.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Portland
Erin Myklebust, Anp, ANP
Nurse Practitioner — Payments: $14,322
Nurse Practitioner $14,322
Mrs. Denise Viekman, Np, NP
Nurse Practitioner — Payments: $11,214
Nurse Practitioner $11,214
Yasmine Lee, Dnp, Anp, DNP, ANP
Nurse Practitioner — Payments: $10,632
Nurse Practitioner $10,632
Jennifer Murdoch, Anp, ANP
Nurse Practitioner — Payments: $10,106
Nurse Practitioner $10,106
Lisa Nazarenus, Apn, APN
Nurse Practitioner — Payments: $6,116
Nurse Practitioner $6,116
Ms. Amy Carter, F.n.p, F.N.P
Nurse Practitioner — Payments: $5,607
Nurse Practitioner $5,607